Meglič L

No ORCID on file · 2 papers in corpus

observational 2026

Thymidine kinase as a biomarker of chemoresistance in epithelial ovarian cancer using the KELIM model

Frontiers in pharmacology ·doi:10.3389/fphar.2026.1617484

BACKGROUND: Ovarian cancer (OC) remains the most lethal gynecological malignancy, with platinum sensitivity being a key determinant of treatment outcomes. The KELIM model, derived from CA-125 kinetics, is a promising biomarker for predictin…

diagnostic-accuracy 2023

A Dual Biomarker TK1 Protein and CA125 or HE4-Based Algorithm as a Better Diagnostic Tool than ROMA Index in Early Detection of Ovarian Cancer

Cancers ·doi:10.3390/cancers15051593

BACKGROUND: The early detection of ovarian cancer is presently not effective, and it is crucial to establish biomarkers for the early diagnosis of ovarian cancer to improve the survival of patients. MATERIALS AND METHODS: The aim of this s…